• Activity INFORMATION

  Overview

  The guideline governing the management of blood cholesterol to reduce cardiovascular risk was revised at the end of 2018. At that time, several critical changes were made to the guideline, including the identification of high-risk and very high-risk factors, restructuring of patient groups in which to consider drug therapy, revised therapeutic targets, and incorporation of select non-statin drugs to the clinical armamentarium. Furthermore, two additional non-statin products have come to market since the guideline’s publication. It is imperative to disseminate these updates to healthcare practitioners, so that they can provide evidence-based, patient-centered care as members of an interdisciplinary team.
  

  Handouts

  • Slide Document :   21256H01_2pp.pdf Download

  • Slide Document :   21256H01_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Identify key recommendations from the 2018 Guideline on the Management of Blood Cholesterol

  Recognize the relationship between high cholesterol and atherosclerotic cardiovascular disease (ASCVD), including risk assessment

  Recognize the role of pharmacotherapy in dyslipidemia management to optimize pharmacotherapy plans and outcomes for patients with dyslipidemia

  Nurse

  Recognize the role of pharmacotherapy in dyslipidemia management to optimize pharmacotherapy plans and outcomes for patients with dyslipidemia

  Identify key recommendations from the 2018 Guideline on the Management of Blood Cholesterol

  Recognize the relationship between high cholesterol and atherosclerotic cardiovascular disease (ASCVD), including risk assessment

• Activity ACCREDITATION

  Activity Type

  Application

  CE Broker

  20-858909

  Universal Activity Number

  Pharmacist 0798-0000-21-256-H01-P
  Nurse 0798-0000-21-256-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Maria  Thurston, PharmD, BCPS, FGSHP, FCCP Clinical Associate Professor, Mercer University College of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).